Loading news...
Even before the purchase, Vireo Growth had a strong third quarter. The Hawthorne subsidiary was seen as a drag on Scotts Miracle-Gro's margins.
Planned share-based transaction is expected to be completed during the first fiscal quarter of 2026 Vireo plans to appoint Chris Hagedorn to its Board of Directors MINNEAPOLIS, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it has entered into a nonbinding Memorandum of Understanding (“MOU”) with The Scotts Miracle-Gro Company to acquire The Hawthorne Gardening Company LLC (“Hawthorne”), an independent operating subsidiary of ScottsMiracle-Gro and leading provider of nutrients, lighting and other materials used for indoor and hydroponic gardening in North America. John Mazarakis, Chief Executive Officer of Vireo, commented, “We've valued our working relationship with ScottsMiracle-Gro and the Hawthorne team, and they have been excellent to work with throughout our discussions.
MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it plans to acquire additional outstanding senior secured convertible notes (the “Notes”) of Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholders. Total outstanding principal plus accrued interest of the acquired Notes is approximately $2.6 million, but the Notes will be acquired at a substantial discount to par value for total consideration of approximately $1.6 million payable in subordinate voting shares of the Company at closing at a price per share of $0.54.
Acquired assets further optimize Vireo's operating footprint in Colorado with addition of 17 dispensaries Transaction expands Vireo's leadership position in the Colorado retail market with 41 total dispensaries Parties also enter into Management Services Agreement through closing which is expected in 1H'26 MINNEAPOLIS, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it and its subsidiary Vireo Health, Inc. have entered into an Asset Purchase Agreement (“APA”) to acquire certain retail assets and properties of PharmaCann Inc. in the State of Colorado. The transaction will expand Vireo's position in Colorado's adult-use retail market to 41 total active dispensaries, and is subject to satisfaction of closing conditions and state and local regulatory approvals.
Vireo Growth Inc. (OTCQX:VREOF) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants John Mazarakis - CEO & Co-Executive Chairman Tyson Macdonald - Chief Financial Officer Conference Call Participants Michael Kim - Zacks Small-Cap Research Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning, and welcome to the Vireo Growth Inc. Third Quarter 2025 Results Call. The company would like to remind everyone that today's conference call may contain forward-looking statements within the meaning of U.S. and Canadian securities laws.
MINNEAPOLIS, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its third fiscal quarter ended September 30, 2025 on Wednesday, November 12, 2025, before the market opens.
CHICAGO and MINNEAPOLIS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) and Verano Holdings Corp. (“Verano”, Vireo and Verano, each a “Company”) (Cboe CA: VRNO) (OTCQX: VRNOF) today announced that they have reached a comprehensive settlement (the “Settlement Agreement”) dismissing all outstanding litigation matters between the two Companies that are pending before the Supreme Court of British Columbia, Canada.
– Transaction reflects continuation of Vireo's M&A strategy and is expected to close later this month – – Transaction reflects continuation of Vireo's M&A strategy and is expected to close later this month –
– Company now dispensing adult-use cannabis at all eight Green Goods® dispensaries in Minnesota – – With a population of 5.7 million, adult-use launch expected to drive strong organic revenue growth – MINNEAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF) today announced that on September 16, 2025, it recorded its first sale of adult use cannabis in Minnesota at its historic downtown Minneapolis Green Goods® dispensary.
MINNEAPOLIS , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), at the request of the Canadian Investment Regulatory Organization (“CIRO”), today confirmed that Company management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.
Vireo Growth Inc. (OTCQX:VREOF) Q2 2025 Earnings Call August 13, 2025 8:30 AM ET Company Participants J. Tyson Macdonald - Chief Financial Officer John Michael Mazarakis - CEO & Co-Executive Chairman Conference Call Participants Pablo Ernesto Zuanic - Zuanic & Associates Sung-Chul Kim - Zacks Small-Cap Research Operator Good morning, and welcome to the Vireo Growth Inc.'s Second Quarter 2025 Results Call.
-- Company completes refinancing of all existing senior secured debt through a $120 million self-syndicated term loan with leading banks, at an interest rate of 8.3% -- -- Company also complies expansion of its consolidated credit facilities with an additional $33 million second lien term loan with $50 million accordion to support ongoing strategic initiatives --
-- Leading cannabis companies partner to leverage existing IP and brand value in New York -- CHICAGO and MINNEAPOLIS, July 01, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), a multi-state, vertically-integrated cannabis operator, is pleased to announce a licensing agreement with Curio Wellness (“Curio”), a cGMP-certified, vertically-integrated cannabis company and market-leading innovator of health and wellness products. This strategic partnership will bring Curio's celebrated Best Self Collection to the rapidly growing New York cannabis market.
MINNEAPOLIS , June 05, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced that it has closed its previously-announced transaction to acquire Missouri-based Proper Brands (“Proper”) through the acquisition of NGH Investments, Inc. and Proper Holdings Management, Inc., subsidiaries of Proper Holdings, LLC, a management company providing services to Proper's portfolio of 11 retail dispensaries in Missouri.
– Acquisitions strengthen profitability and competitive position with proprietary technology platform – – Missouri and Nevada transactions remain on track to close during the second quarter of 2025 – MINNEAPOLIS, May 12, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it has closed its previously-announced transactions to acquire Utah-based WholesomeCo Cannabis (“Wholesome”) and the Arches proprietary technology and analytics platform. Wholesome is a dominant player in the Utah medical market, fueled by a large delivery operation with one single dispensary.
Vireo Growth Inc. (VREOF) Q1 2025 Earnings Call Transcript
– Q1 revenue of $24.5 million increased 1.9% year-over-year, in line with expectations for Vireo's established markets –
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its first fiscal quarter ended March 31, 2025 on Friday, May 9, 2025 before the market opens.
Vireo Growth Inc. (OTCQX:VREOF) Q4 2024 Earnings Conference Call March 4, 2025 8:30 AM ET Company Participants John Mazarakis - Co-Executive Chairman and Chief Executive Officer Tyson Macdonald - Chief Financial Officer Conference Call Participants Eric Des Lauriers - Craig-Hallum Capital Group Operator Good morning, and welcome to Vireo Growth Inc's. Fourth Quarter and Full Year 2024 Results Call.